Proposed response parameters for 12 months drug trial in Juvenile Systemic Sclerosis. Results of the Hamburg International Consensus Meetings
Related Posts
Thorp M, Balakasi K, van Oosterhout JJ, Ramesh M, Robson I, Choko A, Shoptaw S, Hoffman R, Cornell M, Dovel K. High-Risk Mobility and Interruption[...]
Heerspink HJL, Neuen BL, Agarwal R, Cherney DZI, Lam CSP, Tuttle KR, Wanner C, Sarafidis P, Chertow GM, Friede T, Barratt J, Floege J, Chew-Wong[...]
Song J, Daniel M, Ardehali A. Not Yet a Nail in the Coffin for Ex Vivo Heart Perfusion. Ann Thorac Surg. 2026 Nov 15:S0003-4975(26)01175-6. doi:[...]